Jeremy Clarkson reveals comical 'Mounjaro problem' as his pants fall down at airport

Jeremy Clarkson, yet again, appears to be having problems with his trousers falling down after making the switch to weight-loss drugs.

The Grand Tour presenter, 65, underwent emergency heart surgery in 2024, and in a bid to change his lifestyle, he kept up with his Ozempic dosage.

But in his previous column for The Times, Clarkson said he 'was sick a lot' because the Type-2 diabetes drug didn't really agree with him.

"My body lost the ability to deal with gluttony but once the initial enthusiasm had worn off, my mind still wanted to breakfast on Cadbury Fruit & Nut," he explained.

Clarkson said in his interview with The Times that after switching to Mounjaro, he 'could open the fridge door, look at all the goodies, then close it'.

However, a key issue he's finding with losing weight is that his pants no longer seem to fit him.

Jeremy Clarkson was told to change his lifestyle after suffering a health scare in 2024 (Stuart C. Wilson/Getty Images)

Taking to X on Saturday (1 November), he recalled a somewhat embarrassing experience at airport security that he 'never saw coming'.

"At airports you’re made to remove your belt and then told to stand in the body scanner with your arms in the air. So you can’t hold your trousers up," he penned.

Now, this isn't the first time Clarkson has complained about his trousers being a bit loose.

During his acceptance speech at the National Television Awards (NTAs) on 10 September, the Clarkson's Farm star was part of the cast who won the Best Factual Entertainment show award.

Clarkson says Mounjaro suits him better than Ozempic (Mike Marsland/WireImage)

Joined on stage by his partner Lisa Hogan, Clarkson joked: "I should explain I'm on Mounjaro, my trousers are falling down.

"Lisa's going to hold my trousers up while I make a very short speech."

The key difference between Mounjaro and Ozempic is that Mounjaro can be prescribed for weight loss in the UK, whereas Ozempic can only be prescribed for patients with Type 2 diabetes and is not approved for weight loss.

Ozempic's manufacturer, Novo Nordisk, has previously told LADbible that Ozempic is a 'prescription-only medicine and requires a healthcare professional to prescribe under strict supervision'.

This remains the case even though semaglutide, the chemical present in Ozempic, is officially licensed for weight loss under the name Wegovy.

According to Diabetes UK, the common side effects of both drugs include:

• Feeling sick

• Diarrhoea

• Risk of low blood sugar

• Risk of high blood sugar

LADbible Group has contacted Ozempic's manufacturer, Novo Nordisk, for comment.